Bilge Sürücü
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bilge Sürücü has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Burcu Uner
Department of Pharmaceutical and Administrative Sciences, University of Health Science and Pharmacy in St. Louis, St. Louis, USA
2 shared publications - Egemen Çakırlı
Department ofPharmaceutical Technology, Faculty of Pharmacy, Acibadem Mehmet Ali Aydinlar University, 34752, Ataşehir, Istanbul,Türkiye
2 shared publications - Samet Özdemir
Department of Pharmaceutical Technology, Faculty of Pharmacy, İstanbul Health and Technology University, Istanbul 34445, Türkiye
2 shared publications - Ali Riza Cenk Celebi
Department of Ophthalmology, Istanbul Medipol University, 34196 Istanbul, Türkiye
1 shared publication - Alptug Karakucuk
Department of Pharmaceutical Technology, Faculty of Pharmacy, Ankara Medipol University, Ankara, Turkey
1 shared publication - Cemre Irem Ayguler
Department of Pharmaceutical Technology, Faculty of Pharmacy, Istanbul University, Istanbul, Türkiye; Department of Pharmaceutical Technology, Faculty of Pharmacy, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Türkiye
1 shared publication
Latest Publications
- 7 July 2023
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 20 (3) , 149-156
Preparation and Characterization Studies of Dorzolamide-Loaded Ophthalmic Implants for Treating Glaucoma
Objectives: This study constructed dorzolamide (DRZ)-loaded ophthalmic implants for extended drug delivery and increased drug retention. Materials and Methods: Carboxymethyl cellulose (CMC) and chitosan (CHI) were used to describe the ophthalmic implants. The implants were prepared by the solvent casting technique in presence of polyethylene glycol 6000 (PEG 6000) as plasticizer. Physicochemical characterization studies including mechanical characteristics [tensile strength (TS), elongation at break, and Young's modulus], bioadhesion studies, and in vitro and ex vivo drug release studies were conducted. Results: TS of drug-loaded ophthalmic implants was 10.70 and 11.68 MPa, respectively. Elongation at break of CMC and CHI implants was 62.00% and 59.05%, respectively. The in vitro release profiles fit into Higuchi type kinetic model. Ex vivo release study results for both implants were correlated with in vitro release investigations. Conclusion: CMC and CHI-based implants provide extended drug delivery. Implants prepared using CMC provided a significantly slower in vitro release rate, and drug retention on ocular surfaces increased. Thus, it has been concluded that DRZ-loaded CMC implants could provide effective treatment for glaucoma.
- 7 July 2023
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 20 (3) , 149-156
Preparation and Characterization Studies of Dorzolamide-Loaded Ophthalmic Implants for Treating Glaucoma
Objectives: This study constructed dorzolamide (DRZ)-loaded ophthalmic implants for extended drug delivery and increased drug retention. Materials and Methods: Carboxymethyl cellulose (CMC) and chitosan (CHI) were used to describe the ophthalmic implants. The implants were prepared by the solvent casting technique in presence of polyethylene glycol 6000 (PEG 6000) as plasticizer. Physicochemical characterization studies including mechanical characteristics [tensile strength (TS), elongation at break, and Young's modulus], bioadhesion studies, and in vitro and ex vivo drug release studies were conducted. Results: TS of drug-loaded ophthalmic implants was 10.70 and 11.68 MPa, respectively. Elongation at break of CMC and CHI implants was 62.00% and 59.05%, respectively. The in vitro release profiles fit into Higuchi type kinetic model. Ex vivo release study results for both implants were correlated with in vitro release investigations. Conclusion: CMC and CHI-based implants provide extended drug delivery. Implants prepared using CMC provided a significantly slower in vitro release rate, and drug retention on ocular surfaces increased. Thus, it has been concluded that DRZ-loaded CMC implants could provide effective treatment for glaucoma.
- 24 February 2022
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 18 (1) , 90-101
Development and Characterization of Viburnum opulus L. Extract-Loaded Orodispersible Films: Potential Route of Administration for Phytochemicals
- 24 February 2022
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 18 (1) , 90-101
Development and Characterization of Viburnum opulus L. Extract-Loaded Orodispersible Films: Potential Route of Administration for Phytochemicals